Multiplex Assays with Fluorescent Microbead Readout: A Powerful Tool, For Mutation Detection (Editorials) Multiplex Assays with Fluorescent Microbead Readout: A Powerful Tool, For Mutation Detection (Editorials)

Multiplex Assays with Fluorescent Microbead Readout: A Powerful Tool, For Mutation Detection (Editorials‪)‬

Clinical Chemistry 2004, Nov, 50, 11

    • €2.99
    • €2.99

Publisher Description

After the completion of the Human Genome Project, the goal for biomedical research is to apply genomic approaches for the improvement of human health (1). The study of human DNA variation promises to have a great impact on understanding how genetic factors contribute to human disease, conferring susceptibility or resistance; it is also expected to help uncover the reasons that individuals respond differentially to therapeutics. Technologies for mutation detection can be classified into methods for the detection of unknown mutations and methods for the detection of known mutations (2). Methods for the detection of unknown mutations (3-8), also known as screening or scanning methods, are used during the discovery phase. Once a new mutation associated with a genetic disease has been characterized and validated, it is usually detected over and over in many DNA samples by specific, cost-efficient, and easy-to-use methods (9-13), also known as "diagnostic methods" (14).

GENRE
Science & Nature
RELEASED
2004
1 November
LANGUAGE
EN
English
LENGTH
12
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
182.5
KB
Molecular Analysis and Genome Discovery Molecular Analysis and Genome Discovery
2011
Gene Discovery for Disease Models Gene Discovery for Disease Models
2011
Methods for Detection of Point Mutations: Performance and Quality Assessment. Methods for Detection of Point Mutations: Performance and Quality Assessment.
1997
Nucleic Acid Detection Technologies--Labels, Strategies, And Formats. Nucleic Acid Detection Technologies--Labels, Strategies, And Formats.
1999
Sequencing with Microarray Technology--a Powerful New Tool for Molecular Diagnostics (Editorial) Sequencing with Microarray Technology--a Powerful New Tool for Molecular Diagnostics (Editorial)
2000
Chemical Diagnostics Chemical Diagnostics
2013
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report) Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs) DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs) Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial) High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial) Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)
2003